謝 茂志

Medicine & Life Sciences

1. Abdominal Abscess 5%
2. Adenocarcinoma 41%
3. Adjuvant Chemoradiotherapy 5%
4. Adjuvant Chemotherapy 8%
5. Adjuvant Radiotherapy 5%
6. Anastomotic Leak 8%
7. Bazex-Dupre-Christol syndrome 5%
8. Breast 5%
9. Breast Neoplasms 8%
10. Carcinoma 30%
11. Chemoradiotherapy 7%
12. Colorectal Neoplasms 5%
13. Confidence Intervals 5%
14. Cytoreduction Surgical Procedures 27%
15. Disease-Free Survival 5%
16. Dissection 6%
17. Drug Therapy 10%
18. Gastrectomy 44%
19. Gastric Stump 10%
20. Goblet Cells 7%
21. Hepatocellular Carcinoma 5%
22. Induced Hyperthermia 32%
23. Liver 7%
24. Lymph Node Excision 9%
25. Lymph Nodes 26%
26. Morbidity 10%
27. Mortality 7%
28. Multivariate Analysis 6%
29. Neoplasm Metastasis 39%
30. Neoplasms 31%
31. Peritoneal Neoplasms 22%
32. Pseudomyxoma Peritonei 10%
33. Randomized Controlled Trials 6%
34. Recurrence 18%
35. Registries 6%
36. Risk Management 7%
37. Serous Membrane 5%
38. Signet Ring Cell Carcinoma 9%
39. Splenectomy 6%
40. Stomach 41%
41. Stomach Neoplasms 100%
42. Survival 40%
43. Survival Rate 15%
44. Taiwan 19%
45. Therapeutics 6%
46. Tissue Polypeptide Antigen 5%
47. Urachus 5%
48. Veterans Hospitals 6%